Validity of 3-methylhistidine excretion as an indicator of skeletal muscle protein breakdown in humans
- PMID: 3138511
- DOI: 10.1016/0026-0495(88)90118-7
Validity of 3-methylhistidine excretion as an indicator of skeletal muscle protein breakdown in humans
Abstract
The urinary excretion of 3-methylhistidine (3MEH) in humans and animals has been used as a biologic marker for skeletal muscle protein breakdown. In rats, it has been recently suggested that there is a significant contribution of 3MEH in urine from the gastrointestinal tract due to the rapid turnover of protein in that tissue. To evaluate this point in humans, six patients with short bowel were evaluated. They were placed on three-day meat-free diets while 24-hour urine collections were obtained. The mean +/- SEM 3MEH in the short-bowel group was 3.27 +/- 0.34 mumol/kg/d and the mean +/- SEM molar ratio of 3MEH to creatinine was 0.0212 +/- 0.0012. These data were not significantly different from the control group at 95% confidence level. The results suggest that the contribution of the small intestine appears to be negligible, therefore urinary 3MEH should continue to be a valid index of skeletal muscle breakdown in man.
Similar articles
-
Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.Biochem J. 1981 Nov 15;200(2):449-52. doi: 10.1042/bj2000449. Biochem J. 1981. PMID: 7340846 Free PMC article.
-
3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.Clin Sci (Lond). 1983 Sep;65(3):217-25. doi: 10.1042/cs0650217. Clin Sci (Lond). 1983. PMID: 6872456 No abstract available.
-
3-Methylhistidine turnover in the whole body, and the contribution of skeletal muscle and intestine to urinary 3-methylhistidine excretion in the adult rat.Biochem J. 1983 Aug 15;214(2):607-15. doi: 10.1042/bj2140607. Biochem J. 1983. PMID: 6615483 Free PMC article.
-
Muscle protein degradation in severely malnourished patients with chronic obstructive pulmonary disease subject to short-term total parenteral nutrition.JPEN J Parenter Enteral Nutr. 1992 May-Jun;16(3):248-54. doi: 10.1177/0148607192016003248. JPEN J Parenter Enteral Nutr. 1992. PMID: 1501355
-
Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview.Fed Proc. 1978 Jul;37(9):2291-300. Fed Proc. 1978. PMID: 350635 Review.
Cited by
-
Greater plasma essential amino acids and lower 3-methylhistidine with higher protein intake during endurance training: a randomised control trial.Amino Acids. 2023 Oct;55(10):1285-1291. doi: 10.1007/s00726-022-03210-z. Epub 2022 Dec 7. Amino Acids. 2023. PMID: 36477889 Clinical Trial.
-
A novel stable isotope tracer method to simultaneously quantify skeletal muscle protein synthesis and breakdown.Metabol Open. 2020 Mar;5:100022. doi: 10.1016/j.metop.2020.100022. Metabol Open. 2020. PMID: 32494771 Free PMC article.
-
Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism.Gut Microbes. 2025 Dec;17(1):2455506. doi: 10.1080/19490976.2025.2455506. Epub 2025 Feb 5. Gut Microbes. 2025. PMID: 39910065 Free PMC article.
-
Effects of recombinant human growth hormone in patients with severe sepsis.Ann Surg. 1992 Dec;216(6):648-55. doi: 10.1097/00000658-199212000-00006. Ann Surg. 1992. PMID: 1466618 Free PMC article. Clinical Trial.
-
Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study.Skelet Muscle. 2021 Dec 11;11(1):27. doi: 10.1186/s13395-021-00282-5. Skelet Muscle. 2021. PMID: 34895316 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical